CXCR3 and COVID-19: Here, we found for the first time that the CXCR3+ population not only increased rapidly in the lung tissue but also in the spleen, PBMCs, and CD8+ cells of old RMs infected with SARS-CoV-2, which appears to be an age-related systemic pathological feature of COVID-19.